The WHO asked countries that have received the vaccine to take appropriate actions, according to the statement, but did not specify what th...

The company said the decision has been taken as it has completed its supply obligations to procurement agencies and is foreseeing decrease ...

Haffkine, owned by the Maharashtra government, and BIBCOL entered licensing agreements with Bharat Biotech to produce a Covaxin drug substa...

The Ankleshwar plant, constructed in 2020, has a manufacturing capacity of more than 10 million doses per month, and supplies will be avail...

Bharat Biotech intends to submit documentation for emergency use authorisation to several additional countries worldwide, the company said.

On the production plan of Covaxin at various facilities, NITI Aayog member (Health) Dr V K Paul said there were some initial hiccups relate...

Union Health Minister Mansukh Mandaviya was responding to a question on the current capacity to manufacture Covaxin and Covishield in the c...

The government is now betting on Indian Immunologicals to boost Covaxin production this year as Haffkine Bio-Pharma managing director Sande...

The government also said that production capacity will be increased: SII expects that Covishield production will go up to more than 120 mil...

According to the Centre's affidavit, over 1.8 million doses of Covaxin are pending against its order for 20 million doses in March.

“For Covaxin, we will see a significant (production) ramp-up of more than double in August-September, when the doses manufactured by Bharat...

The mismatch between reported production numbers of Covid vaccines in India and the level of daily vaccination seems particularly acute in ...

The government also intends to take up the matter with the World Health Organisation (WHO) to step up Covaxin production.

"The company plans to produce 200 million doses of Covaxin per annum in the GMP facilities that are already operational for the production ...

The Hyderabad-based vaccine and bio-therapeutics firm has repurposed its veterinary vaccine plant at Malur industrial area near Bengaluru t...

Investing in upgrading a BSL-3 lab to make it fit for production will have uses beyond the manufacture of Covaxin. Going beyond the financi...

Giving details, of the 127,605,870 COVID-19 vaccination jabs administered till now, 11,60,65,107 are of Covishield while 1,15,40,763 are of...